PremiumThe FlyDr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection Dr. Reddy’s Laboratories to Engage with Investors at Upcoming Conference Dr. Reddy’s Faces Tax Penalty, Evaluates Appeal PremiumCompany AnnouncementsDr. Reddy’s Expands Oncology Portfolio with Henlius Partnership Dr. Reddy’s enters commercialization agreement with Henlius for HLX15 Dr. Reddy’s Laboratories Schedules Investor Conference Participation PremiumCompany AnnouncementsDr. Reddy’s Laboratories Reports Strong Q3FY25 Financial Results Dr. Reddy’s Laboratories to Engage in Upcoming Investor Conference Dr. Reddy’s Earnings Call Highlights Record Growth